UBS Group Portfolio holdings
UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.82B |
| 2 |
Linde
LIN
|
+$786M |
| 3 |
Energy Transfer Partners
ET
|
+$666M |
| 4 |
VanEck Gold Miners ETF
GDX
|
+$445M |
| 5 |
UBS Group
UBS
|
+$416M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ETP
Energy Transfer Partners, L.P.
ETP
|
+$1.06B |
| 2 |
Colgate-Palmolive
CL
|
+$665M |
| 3 |
PX
Praxair Inc
PX
|
+$528M |
| 4 |
Apple
AAPL
|
+$503M |
| 5 |
Amazon
AMZN
|
+$468M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 8.03% |
| 2 | Financials | 6.64% |
| 3 | Healthcare | 6.26% |
| 4 | Consumer Discretionary | 5.11% |
| 5 | Industrials | 4.91% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2826
Otter Tail
OTTR
$3.91B
| $2.46M | ﹤0.01% |
49,606
+5,730
| +13% | +$273K |
|
2827
Chemours
CC
$2.27B
| $2.46M | ﹤0.01% |
87,154
-40,079
| -32% | -$1.27M |
|
2828
Maximus
MMS
$3.06B
| $2.46M | ﹤0.01% |
37,719
-116,615
| -76% | -$7.67M |
|
|
ACOR
2829
DELISTED
Acorda Therapeutics
ACOR
| $2.45M | ﹤0.01% |
1,311
+1,069
| +442% | +$2.33M |
|
|
PHT
2830
DELISTED
Pioneer High Income Fund
PHT
| $2.45M | ﹤0.01% |
307,152
+35,291
| +13% | +$303K |
|
|
AVK
2831
Advent Convertible and Income Fund
AVK
$560M
| $2.44M | ﹤0.01% |
200,204
+26,118
| +15% | +$353K |
|
|
2832
CALL
Energy Transfer Partners
ET
$71.2B
| $2.44M | ﹤0.01% |
185,100
-200,000
| -52% | -$3.04M |
|
|
AHL
2833
DELISTED
ASPEN Insurance Holding Limited
AHL
| $2.44M | ﹤0.01% |
58,238
+51,765
| +800% | +$2.16M |
|
2834
CALL
International Paper
IP
$21.5B
| $2.44M | ﹤0.01% |
63,782
| – | – |
|
|
EHT
2835
DELISTED
Eaton Vance 2021 Target Term Trust
EHT
| $2.43M | ﹤0.01% |
272,820
-47,735
| -15% | -$450K |
|
2836
iShares Core International Aggregate Bond Fund
IAGG
$11B
| $2.43M | ﹤0.01% |
46,506
+13,200
| +40% | +$688K |
|
2837
WhiteHorse Finance
WHF
$143M
| $2.42M | ﹤0.01% |
190,540
-9,082
| -5% | -$120K |
|
|
EVM
2838
DELISTED
Eaton Vance California Municipal Bond Fund
EVM
| $2.42M | ﹤0.01% |
244,740
+5,950
| +2% | +$58.9K |
|
|
CIT
2839
DELISTED
CIT Group Inc.
CIT
| $2.42M | ﹤0.01% |
63,304
-5,009
| -7% | -$227K |
|
|
AAWW
2840
DELISTED
Atlas Air Worldwide Holdings, Inc.
AAWW
| $2.42M | ﹤0.01% |
57,372
+3,426
| +6% | +$175K |
|
|
BITA
2841
DELISTED
Bitauto Holdings Limited
BITA
| $2.42M | ﹤0.01% |
97,498
-1,744,591
| -95% | -$33.9M |
|
2842
Invesco Pharmaceuticals ETF
PJP
$477M
| $2.41M | ﹤0.01% |
38,651
-48,253
| -56% | -$3.26M |
|
2843
Tenet Healthcare
THC
$20.7B
| $2.4M | ﹤0.01% |
140,251
-22,654
| -14% | -$548K |
|
2844
Anika Therapeutics
ANIK
$270M
| $2.4M | ﹤0.01% |
71,470
+8,616
| +14% | +$311K |
|
2845
BlackRock Resources & Commodities Strategy Trust
BCX
$917M
| $2.4M | ﹤0.01% |
339,892
-67,338
| -17% | -$532K |
|
|
2846
PUT
Colgate-Palmolive
CL
$74.1B
| $2.4M | ﹤0.01% |
40,300
-160,200
| -80% | -$10M |
|
|
MVC
2847
DELISTED
MVC Capital, Inc.
MVC
| $2.4M | ﹤0.01% |
292,046
-28,355
| -9% | -$254K |
|
2848
FTAI Aviation
FTAI
$22.7B
| $2.39M | ﹤0.01% |
195,121
-5,430
| -3% | -$75.7K |
|
|
BDN
2849
Brandywine Realty Trust
BDN
$554M
| $2.38M | ﹤0.01% |
185,305
-78,536
| -30% | -$1.11M |
|
2850
Iovance Biotherapeutics
IOVA
$2.77B
| $2.38M | ﹤0.01% |
269,494
+223,833
| +490% | +$2.16M |
|
Similar funds
UBS Group's Q4 2018 Portfolio in Review
As of Q4 2018, UBS Group held 8,767 positions worth $221B, down 13% from $252B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
UBS Group's Q4 2018 filing shows 731 new, 3,710 increased, 3,260 reduced and 648 closed positions. Its largest new stake was Linde: 4,971,408 shares worth $776M. The largest sale was Energy Transfer Partners, L.P., an estimated $1.06B.
By sector, the portfolio is most concentrated in Technology at 8% of assets, down from 9.3% a quarter earlier, followed by Financials and Healthcare.
- UBS Group's largest Q4 2018 buy was Linde: 4,971,408 shares worth $776M.
- UBS Group added most to State Street SPDR S&P 500 ETF Trust in Q4 2018, an estimated $1.82B increase.
- UBS Group's biggest Q4 2018 reduction was Colgate-Palmolive, cutting an estimated $665M.
- UBS Group fully exited Energy Transfer Partners, L.P. in Q4 2018, selling an estimated $1.06B.
- UBS Group's ten largest holdings make up 15% of its $221B portfolio in Q4 2018.
- UBS Group opened 731 new positions and closed 648 in Q4 2018.
- UBS Group's portfolio value fell 13% quarter-over-quarter to $221B.
Based on UBS Group's 13F filing for Q4 2018, filed 14 Feb 2019.